Improved right ventricular function following transapical transcatheter mitral valve implantation for severe mitral regurgitation

Background: Transapical transcatheter mitral valve implantation (TMVI) may be a therapeutic option for patients with severe mitral regurgitation (MR) excluded from cardiac surgery due to excessive risk. Exclusion criteria frequently include pulmonary hypertension and right ventricular (RV) dysfuncti...

Full description

Bibliographic Details
Main Authors: Sara Hungerford, Nicole Bart, Paul Jansz, Sharon Kay, Sam Emmanuel, Mayooran Namasivayam, Gry Dahle, Alison Duncan, Christopher Hayward, David W.M. Muller
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906720303857